Infectious Diseases
Conference Coverage
Don’t shorten therapy for older, sicker cellulitis patients
Elderly patients with cellulitis and comorbid conditions probably need a full 12-day course of treatment.
News from the FDA/CDC
Inadequate antibiotic use persists in gonorrhea
In 2016, about one in five gonorrhea cases did not receive recommended treatment.
From the Journals
Very few infants born to HCV-infected mothers receive testing
Despite increasing prevalence of hepatitis C virus infection in pregnant women, infants exposed to the disease are screened at a very low rate.
Conference Coverage
Most HIV patients need treatment for acute HCV
Fewer than 12% of HIV infected men will clear new hepatitis C infections on their own and thus need DAA treatment.
Latest News
Phase 2 ‘universal flu vaccine’ trial announced
NIAID announced that is sponsoring a phase 2 trial of a universal flu vaccine, M-001, which could protect against many current and emerging...
From the Journals
Too few Michigan children with SCD receive pneumococcal, meningococcal vaccines
Children with SCD still were doing better than those without the disease in up-to-date vaccination status.
Conference Coverage
New drugs provide new options in HCC
PHILADELPHIA – “We are on the cusp where new compounds not only are being tested, but they are being approved.”
From the Journals
Interferon-gamma release assay trumps tuberculin skin test in school-aged children
IGRA shows significantly greater sensitivity as an adjunct diagnostic test for children aged 5-18 years with diagnosed TB.
News
FDA advisory committee votes to recommend first once-daily aminoglycoside antibiotic
Plazomicin has been recommended by an FDA advisory committee as an added treatment for complicated UTI.
Conference Coverage
Treatment of HCV in special populations
MAUI, HAWAII – Acute hepatitis C infection sometimes warrants treatment.
Conference Coverage
Use these two questions to simplify H. pylori treatment choice
New guidelines recommend two different treatment regimens, depending on the answers.